Lewis H. Bender
President and CEO, Director · INTENSITY THERAPEUTICS, INC.
Individual
- 2025
- Jul 20, 2026
- 3
Other insiders active in the same sector
No other insider has filed at Lewis H. Bender's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Stephen Hoge - $45.45M in MRNA purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- James C. Foster - $43.26M in CRL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lewis H. Bender?
Lewis H. Bender is a corporate insider, tracked as President and CEO, Director of INTENSITY THERAPEUTICS, INC. (INTS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lewis H. Bender last file a Form 4?
The most recent primary Form 4 on record is dated 20 July 2026, one of 3 filings going back to 2025.
